This makes schizophrenia the most costly mental illness in the United States . The "e-CAeSAR" trial is the first time neuroscientists will work with U.S. Food and Drug Administration representatives to evaluate Brain Plasticity's program. Pharmaceutical companies have tested drugs in development...
FULL ARTICLE AT PR Newswire